[1]
“Real-world efficacy of ramucirumab plus paclitaxel with or without nivolumab in advanced gastric and gastroesophageal junction cancers”, Ann Med Res , vol. 33, no. 3, pp. 091–098, Mar. 2026, Accessed: Mar. 30, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/4905